ABIM Endocrinology Board Call for Nominations

The American Board of Internal Medicine (ABIM) Endocrinology, Diabetes, and Metabolism Board is looking for an endocrinologist practicing in a private/community setting whose term would begin July 1, 2021.

ABIM Governance members help define the breadth of knowledge of Board-certified physicians, provide perspective on trends and scope of their discipline and collaborate with peers to develop the fairest and most up-to-date assessments possible. Participating in ABIM governance provides a meaningful and rewarding opportunity to join outstanding colleagues in service to the patients and the profession.

The Endocrinology, Diabetes, and Metabolism Board is just one of ABIM’s twelve Specialty Boards that undertake the frontline work at the discipline-specific level. Specialty Boards are responsible for the broad definition of the discipline across Certification and MOC. ABIM has a Specialty Board for all disciplines solely sponsored and administered by ABIM. Specialty Boards have oversight of the exam committees and are responsible for making Certification and MOC relevant vehicles in their discipline.

The role of the Specialty Boards is to:

  • Define, refine, and set standards in Certification and MOC in the discipline;
  • Perform oversight/review of performance assessments in the discipline; and
  • Build partnerships with societies and other organizational stakeholders in support of ABIM work.

ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

The application deadline is September 30, 2020 so be sure to apply today!

You may also like

  • Webinar Will Examine Concerns Around Compounding Anti-Obesity Medications

    Endocrine Society to host virtual Science Writers Conference Nov. 14 Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14. What:…

  • Bianco Named Vice President and Vice Provost for Research, Chief Research Officer at UTMB

    Antonio Bianco, MD, PhD, has joined the University of Texas Medical Branch (UTMB) as vice president and vice provost, research, and chief research officer, effective Sept. 1. A renowned physician-scientist, scholar, and research leader, Bianco possesses an impressive academic career that includes influential contributions to the field of thyroid diseases and an enduring commitment to…

Find more in